United States · 
What does Norwich Ventures invest in?
Norwich Ventures invests most often at Series A and Seed (50% of the rounds on record), in sectors such as Medtech and Healthcare.
Norwich Ventures highlights
- 01
6 rounds on record
- 02
Mostly Series A and Seed: 50% of its rounds
- 03
Sole investor in 2 rounds, median $5.4M
- 04
1 exits from the portfolio
What they do
Norwich is a specialized venture capital firm founded in 2004 with a focus on early-stage medtech.From their own website
- Type
- VC firm
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- MedtechHealthcare
- Based in
- Waltham, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2015
1 round
- Mar
- 2013
2 rounds
- May
- Mar
- 2011
1 round
- Dec
- 2009
1 round
- Oct
- 2007
1 round
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
AMAaron Matthew SandoskiManaging Director, Sole Member and Manager of Norwich 2013 GP, LLCiForm ADV
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$27Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Norwich Ventures Management, LLC
- SEC number
- CRD 170981
What they claim to have backed
From their own portfolio page (on their website)
2 of 3 we have independently watched raise
podimetricsvaxessScreen Shot
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Rhythmia MedicalBought by Boston ScientificUndisclosedOct 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.